MediPal Holdings Corporation
MAHLY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $3,671,328,000 | $3,558,732,000 | $3,360,008,000 | $3,290,921,000 |
| % Growth | 3.2% | 5.9% | 2.1% | – |
| Cost of Goods Sold | $3,415,569,000 | $3,312,077,000 | $3,147,891,000 | $3,085,809,000 |
| Gross Profit | $255,758,000 | $246,655,000 | $212,117,000 | $205,112,000 |
| % Margin | 7% | 6.9% | 6.3% | 6.2% |
| R&D Expenses | $0 | $991,000 | $103,000 | $108,000 |
| G&A Expenses | $0 | $165,203,000 | $144,235,000 | $140,762,000 |
| SG&A Expenses | $23,593,000 | $185,677,000 | $163,040,000 | $159,379,000 |
| Sales & Mktg Exp. | $23,593,000 | $20,474,000 | $18,805,000 | $18,617,000 |
| Other Operating Expenses | $176,557,000 | $12,657,000 | $0 | $0 |
| Operating Expenses | $200,150,000 | $199,325,000 | $163,143,000 | $159,487,000 |
| Operating Income | $55,609,000 | $47,331,000 | $48,974,000 | $45,625,000 |
| % Margin | 1.5% | 1.3% | 1.5% | 1.4% |
| Other Income/Exp. Net | $21,125,000 | $27,410,000 | $21,087,000 | $11,657,000 |
| Pre-Tax Income | $76,734,000 | $74,741,000 | $70,061,000 | $57,284,000 |
| Tax Expense | $25,203,000 | $22,973,000 | $21,738,000 | $18,087,000 |
| Net Income | $40,279,000 | $41,474,000 | $38,806,000 | $29,423,000 |
| % Margin | 1.1% | 1.2% | 1.2% | 0.9% |
| EPS | 193.19 | 195.83 | 184.82 | 140.13 |
| % Growth | -1.3% | 6% | 31.9% | – |
| EPS Diluted | 193.19 | 195.83 | 179.12 | 131.41 |
| Weighted Avg Shares Out | 208,491 | 211,785 | 209,962 | 209,962 |
| Weighted Avg Shares Out Dil | 208,491 | 211,785 | 216,346 | 223,123 |
| Supplemental Information | – | – | – | – |
| Interest Income | $50,000 | $29,000 | $101,000 | $177,000 |
| Interest Expense | $7,000 | $8,000 | $34,000 | $16,000 |
| Depreciation & Amortization | $18,417,000 | $17,982,000 | $14,648,000 | $14,338,000 |
| EBITDA | $95,158,000 | $65,313,000 | $63,622,000 | $59,963,000 |
| % Margin | 2.6% | 1.8% | 1.9% | 1.8% |